LBX Pharmacy Chain Joint Stock Company (SHSE:603883) agreed to acquire 35% stake in Yangzhou Baixinyuan Pharmaceutical Chain Co., Ltd. from Chen Jinxi for CNY210 million on October 30, 2023. This transaction has been reviewed and approved by the 31st meeting of LBX Pharmacy Chain Joint Stock Company fourth board of directors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.12 CNY | +0.69% | +0.97% | +7.46% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.46% | 2.59B | |
-11.64% | 3.62B | |
-0.09% | 3.36B | |
-23.44% | 3.06B | |
-9.26% | 1.75B | |
+9.30% | 1.35B | |
-20.60% | 957M | |
-38.42% | 704M | |
-0.53% | 450M | |
-1.85% | 370M |
- Stock Market
- Equities
- 603883 Stock
- News LBX Pharmacy Chain
- LBX Pharmacy Chain Joint Stock Company agreed to acquire 35% stake in Yangzhou Baixinyuan Pharmaceutical Chain Co., Ltd. from Chen Jinxi for CNY210 million.